US 10973805
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted A61KA61K31/4355A61K31/437
Quick answer
US patent 10973805 (Macrocyclic azolopyridine derivatives as EED and PRC2 modulators) held by Fulcrum Therapeutics, Inc. expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fulcrum Therapeutics, Inc.
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4355, A61K31/437, A61K45/06, A61P